Status:

ACTIVE_NOT_RECRUITING

A Study of a Plant-Based Diet in People With Monoclonal Gammopathy of Undetermined Significance (MGUS) or Smoldering Multiple Myeloma (SMM)

Lead Sponsor:

Memorial Sloan Kettering Cancer Center

Conditions:

Monoclonal Gammopathy of Undetermined Significance

Smoldering Multiple Myeloma

Eligibility:

All Genders

18+ years

Phase:

NA

Brief Summary

This study will test whether a plant-based diet is practical (feasible) for overweight people with monoclonal gammopathy of undetermined significance (MGUS) or smoldering multiple myeloma (SMM). The r...

Eligibility Criteria

Inclusion

  • BMI ≥25
  • Confirmed diagnosis of MGUS or SMM
  • M spike (immunoglobulin) ≥0.2 g/dL or abnormal free light chain ratio with increased level of the appropriate involved light chain
  • Secretory disease
  • Age ≥18 years
  • Willingness to comply with all study-related procedures
  • ECOG performance status of 0-3
  • Interest to learn to cook plant based recipes

Exclusion

  • Patients that already follow a whole foods plant based or vegan diet (ovo-lactovegetarian diets are not excluded)
  • Legume allergy
  • Severe allergies, such as anaphylactic shock to peanuts
  • Concurrent participation in weight loss/dietary/exercise programs
  • Mental impairment leading to inability to cooperate
  • Enrollment onto any other therapeutic investigational study
  • Concurrent pregnancy
  • Patients with a known diagnosis of diabetes mellitus will not be excluded but will need to be followed regularly with an endocrinologist/primary care physician during the trial period.
  • Positive HBV, HCV, HIV PCR testing
  • Non English speaking
  • ≥ Grade 2 electrolyte abnormalities as defined by CTCAEv5.0 (need to be resolved before enrolling on study)
  • If in the opinion of the investigator there maybe any concerns regarding the ability of the patient to complete the study safely

Key Trial Info

Start Date :

June 3 2021

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

June 1 2026

Estimated Enrollment :

23 Patients enrolled

Trial Details

Trial ID

NCT04920084

Start Date

June 3 2021

End Date

June 1 2026

Last Update

September 9 2025

Active Locations (7)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (7 locations)

1

Memorial Sloan Kettering Basking Ridge

Basking Ridge, New Jersey, United States, 07920

2

Memorial Sloan Kettering Monmouth

Middletown, New Jersey, United States, 07748

3

Memorial Sloan Kettering Bergen

Montvale, New Jersey, United States, 07645

4

Memorial Sloan Kettering Commack

Commack, New York, United States, 11725